PolyTouch was acquired by Covidien in 2011.
PolyTouch has developed PatchAssist™, an FDA-cleared laparoscopic surgical instrument that enables accurate and rapid delivery and placement of soft tissue prosthetics (including hernia mesh products) for a variety of procedures, including laparoscopic ventral hernia repair (LVHR).
Proper mesh deployment and placement in laparoscopic hernia repair is crucial to a patient’s quick recovery, low post-procedure morbidity and reduced rate of hernia recurrence. To date, no accurate, standard, and objective method exists. PolyTouch Medical’s novel device enables accurate abdominal cavity mesh placement, potentially reducing operation time by 30%-50%.
In the media: Covidien acquires PolyTouch Medical
There are more than 400,000 ventral hernia repair procedures performed annually in the United States, with 45% performed laparoscopically. While the total number of VHR procedures is growing at a rate of 8%, the number of LVHR procedures is growing almost 3 times faster at 21%, emphasizing the need for solutions that will shorten the procedure and will reduce the learning curve. The total worldwide market potential for PatchAssist is estimated at $300 million.
Minimally invasive treatment of heart valve disease
A more efficient ablation catheter to treat atrial fibrillation
Preventing the development of pressure sores
Novel treatment for vertebral compression fractures
Preventing catheter-associated urinary tract infections (CAUTIs)
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer